{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:47:09Z","timestamp":1787316429895,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cellsig.2023.110742","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T03:55:01Z","timestamp":1685591701000},"page":"110742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dual targeting of melanoma translation by MNK\/eIF4E and PI3K\/mTOR inhibitors"],"prefix":"10.1016","volume":"109","author":[{"given":"Dorota","family":"Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zarzycka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pabijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Lekka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Duli\u0144ska-Litewka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cellsig.2023.110742_bb0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/cancers13051115","article-title":"Resistance to molecularly targeted therapies in melanoma","volume":"13","author":"Patel","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110742_bb0010","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bbamcr.2016.01.025","article-title":"Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling","volume":"1863","author":"Paluncic","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.cellsig.2023.110742_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101543","article-title":"Genetic and genomic pathways of melanoma development, invasion and metastasis","volume":"12","author":"Motwani","year":"2021","journal-title":"Genes (Basel)"},{"issue":"17","key":"10.1016\/j.cellsig.2023.110742_bb0020","first-page":"3660","article-title":"Disruption of the MMAC1\/PTEN gene by deletion or mutation is a frequent event in malignant melanoma","volume":"57","author":"Guldberg","year":"1997","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110742_bb0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1541-7786.MCR-08-0366","article-title":"Targeting melanoma with dual phosphoinositide 3-kinase\/mammalian target of rapamycin inhibitors","volume":"7","author":"Marone","year":"2009","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110742_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell. Signal."},{"issue":"24","key":"10.1016\/j.cellsig.2023.110742_bb0035","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/1078-0432.CCR-10-1490","article-title":"Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma","volume":"16","author":"Aziz","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"37","key":"10.1016\/j.cellsig.2023.110742_bb0040","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1038\/s41388-021-01911-5","article-title":"Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cellsig.2023.110742_bb0045","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.3390\/ijms21114055","article-title":"The MNK1\/2-eIF4E Axis as a potential therapeutic target in melanoma","volume":"21","author":"Prabhu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110742_bb0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbagrm.2014.09.007","article-title":"eIF4E-mediated translational control of cancer incidence","volume":"1849","author":"Bitterman","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110742_bb0055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BST20150126","article-title":"Signalling to eIF4E in cancer","volume":"43","author":"Siddiqui","year":"2015","journal-title":"Biochem. Soc. Trans."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110742_bb0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbagrm.2014.10.003","article-title":"Mnks, eIF4E phosphorylation and cancer","volume":"1849","author":"Proud","year":"2015","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"issue":"28","key":"10.1016\/j.cellsig.2023.110742_bb0065","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2174\/0929867324666170203123427","article-title":"Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for Cancer therapy: recent Progress in the development of MNK inhibitors","volume":"24","author":"Dreas","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2023.110742_bb0070","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1172\/JCI91258","article-title":"MNK1\/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma","volume":"127","author":"Zhan","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110742_bb0075","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/2159-8290.CD-20-0652","article-title":"MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression","volume":"11","author":"Knight","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2023.110742_bb0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20171158","article-title":"Drug discovery targeting the mTOR pathway","volume":"132","author":"Martelli","year":"2018","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110742_bb0085","doi-asserted-by":"crossref","first-page":"e55096","DOI":"10.1371\/journal.pone.0055096","article-title":"Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.cellsig.2023.110742_bb0090","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.cellsig.2023.110742_bb0095","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/MCB.00760-07","article-title":"Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"13","key":"10.1016\/j.cellsig.2023.110742_bb0100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.4155\/fmc-2017-0062","article-title":"Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers","volume":"9","author":"Lineham","year":"2017","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110742_bb0105","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3390\/ijms21082825","article-title":"Synergistic effects of combination therapy with AKT and mTOR inhibitors on bladder Cancer cells","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110742_bb0110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/1535-7163.MCT-14-0669","article-title":"Dual PI3K\/mTOR inhibitors induce rapid Overactivation of the MEK\/ERK pathway in human pancreatic Cancer cells through suppression of mTORC2","volume":"14","author":"Soares","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110742_bb0115","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.18632\/oncotarget.13987","article-title":"Dual inhibition of the PI3K\/AKT\/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications","volume":"8","author":"Fourneaux","year":"2017","journal-title":"Oncotarget."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110742_bb0120","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"10.1016\/j.cellsig.2023.110742_bb0125","doi-asserted-by":"crossref","first-page":"27787","DOI":"10.18632\/oncotarget.8497","article-title":"CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway","volume":"7","author":"Wen","year":"2016","journal-title":"Oncotarget."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110742_bb0130","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1158\/0008-5472.CAN-10-2954","article-title":"PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression","volume":"71","author":"Paraiso","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110742_bb0135","doi-asserted-by":"crossref","first-page":"109642","DOI":"10.1016\/j.cellsig.2020.109642","article-title":"Integrin linked kinase regulates endosomal recycling of N-cadherin in melanoma cells","volume":"72","author":"Gil","year":"2020","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110742_bb0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/092986712803414006","article-title":"The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines","volume":"19","author":"Cio\u0142czyk-Wierzbicka","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110742_bb0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.advenzreg.2010.09.005","article-title":"The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT)","volume":"51","author":"Gil","year":"2011","journal-title":"Adv. Enzym. Regul."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110742_bb0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ccell.2018.11.008","article-title":"p62\/SQSTM1 fuels melanoma progression by opposing mRNA decay of a selective set of pro-metastatic factors","volume":"35","author":"Karras","year":"2019","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2023.110742_bb0155","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4161\/auto.29395","article-title":"The autophagic roles of Rab small GTPases and their upstream regulators: a review","volume":"10","author":"Szatm\u00e1ri","year":"2014","journal-title":"Autophagy."},{"issue":"16","key":"10.1016\/j.cellsig.2023.110742_bb0160","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.3390\/ijms20163916","article-title":"Multitasking Rab proteins in autophagy and membrane trafficking: a focus on Rab33b","volume":"20","author":"Morgan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110742_bb0165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110742_bb0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1523-1747.2000.00068.x","article-title":"Matrix metalloproteinases in human melanoma","volume":"115","author":"Hofmann","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellsig.2023.110742_bb0175","first-page":"753","article-title":"Translational control by oncogenic signaling pathways","volume":"2015","author":"Gao","year":"1849","journal-title":"BBA"},{"issue":"7","key":"10.1016\/j.cellsig.2023.110742_bb0180","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/ijms22073682","article-title":"Inhibition effect of chloroquine and integrin-linked kinase knockdown on translation in melanoma cells","volume":"22","author":"Gil","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2023.110742_bb0185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cyto.2016.01.024","article-title":"Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia","volume":"89","author":"Kosciuczuk","year":"2017","journal-title":"Cytokine."},{"issue":"18","key":"10.1016\/j.cellsig.2023.110742_bb0190","doi-asserted-by":"crossref","first-page":"14148","DOI":"10.18632\/oncotarget.24354","article-title":"Synergistic effects of inhibiting the MNK-eIF4E and PI3K\/AKT\/ mTOR pathways on cell migration in MDA-MB-231 cells","volume":"9","author":"Lineham","year":"2018","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110742_bb0195","first-page":"596","article-title":"Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy","volume":"4","author":"Romagnoli","year":"2021","journal-title":"Cancer Drug Resist."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110742_bb0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1158\/0008-5472.CAN-08-3389","article-title":"Basal subtype and MAPK\/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition","volume":"69","author":"Mirzoeva","year":"2009","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.cellsig.2023.110742_bb0205","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","article-title":"MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors","volume":"72","author":"Turke","year":"2012","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2023.110742_bb0210","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/1878-0261.12102","article-title":"MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701","volume":"11","author":"Chen","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cellsig.2023.110742_bb0215","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fonc.2020.00322","article-title":"Autophagy regulation by the translation machinery and its implications in Cancer","volume":"10","author":"Acevo-Rodr\u00edguez","year":"2020","journal-title":"Front. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:10:40Z","timestamp":1760267440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":43,"alternative-id":["S0898656823001560"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110742","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of melanoma translation by MNK\/eIF4E and PI3K\/mTOR inhibitors","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110742"}}